Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 9,245 shares at $46.10 ($427K) on 2023-02-22, disclosed to the SEC on 2023-02-22.
Seasonal sale ($427k) by EVP&Pres, Periph Intervent — this insider has traded BSX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.23 | 1,279 | $59K | 13.8% |
| 2 | $46.32 | 2,313 | $107K | 25.1% |
| 3 | $46.32 | 2,313 | $107K | 25.1% |
| 4 | $46.10 | 3,340 | $154K | 36.0% |
| Total | $46.23 avg | 9,245 | $427K | 100% |
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |